You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 22, 2025

Drug Price Trends for CLOBETASOL EMOLLIENT


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for CLOBETASOL EMOLLIENT

Average Pharmacy Cost for CLOBETASOL EMOLLIENT

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
CLOBETASOL EMOLLIENT 0.05% CRM 51672-1297-03 0.62598 GM 2025-03-19
CLOBETASOL EMOLLIENT 0.05% CRM 62559-0980-15 0.82735 GM 2025-03-19
CLOBETASOL EMOLLIENT 0.05% CRM 00168-0301-15 0.82735 GM 2025-03-19
CLOBETASOL EMOLLIENT 0.05% CRM 51672-1297-02 0.65530 GM 2025-03-19
CLOBETASOL EMOLLIENT 0.05% CRM 62559-0980-60 0.62598 GM 2025-03-19
CLOBETASOL EMOLLIENT 0.05% CRM 00168-0301-60 0.62598 GM 2025-03-19
CLOBETASOL EMOLLIENT 0.05% CRM 00168-0301-30 0.65530 GM 2025-03-19
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for Clobetasol Propionate

Introduction to Clobetasol Propionate

Clobetasol propionate is a potent topical corticosteroid used to treat various skin conditions, including atopic dermatitis, psoriasis, and other dermatological disorders. The market for clobetasol propionate is robust and growing, driven by increasing demand for effective treatments for skin ailments.

Market Size and Growth Projections

The global clobetasol propionate market is anticipated to experience significant growth over the next few years. As of 2023, the market was valued at approximately USD 1.4 billion and is projected to reach USD 1.6 billion by 2030, growing at a Compound Annual Growth Rate (CAGR) of 5.7% during the forecast period[4].

Segment Analysis by Type

The clobetasol propionate market is segmented based on the purity of the active pharmaceutical ingredient (API). The main segments are:

Purity ≥ 99%

This segment is expected to dominate the market due to the high demand for high-purity APIs in pharmaceutical formulations. The purity of the API is crucial for ensuring the efficacy and safety of the final product[1].

Purity < 99%

Although this segment is smaller, it still holds significance for certain applications where lower purity levels are acceptable.

Segment Analysis by Application

Clobetasol propionate is available in various formulations, each catering to different skin conditions and patient needs.

Aerosol

Aerosol formulations are convenient for treating large skin areas and are popular for their ease of application.

Cream

Creams are widely used for treating skin conditions such as eczema and psoriasis due to their moisturizing properties.

Liniment

Liniments are less common but are used for specific skin conditions where a liquid formulation is preferred.

Scalp Dressing

Scalp dressings are specialized for treating scalp conditions like psoriasis and dermatitis.

Shampoo

Topical shampoos are used for scalp conditions and are gaining popularity due to their targeted application.

Solution

Solutions are versatile and can be used for various skin conditions, including those requiring a liquid formulation.

Regional Market Analysis

The global clobetasol propionate market is segmented into several regions, including North America, Europe, Asia-Pacific, South America, and the Middle East and Africa. The Asia-Pacific region is expected to be a significant growth driver due to increasing R&D spending and a large patient population[3].

Competitive Landscape

The market is highly competitive with several key players:

  • GlaxoSmithKline plc
  • Pfizer Inc.
  • LEO Pharma A/S
  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V.
  • Zydus Cadila
  • Sun Pharmaceutical Industries Ltd.
  • Lupin Limited
  • Taro Pharmaceutical Industries Ltd.
  • Glenmark Pharmaceuticals Ltd.
  • Perrigo Company plc
  • Cipla Ltd.

These companies are focusing on new product developments, mergers, and acquisitions to maintain their market share[3].

Price Projections

The prices of clobetasol propionate formulations vary widely depending on the type of formulation, quantity, and region.

Topical Ointment

For example, the cost for clobetasol topical 0.05% ointment can range from $16.84 to $44.13 for a 15-gram supply, depending on the pharmacy and location[2].

Topical Shampoo

The price for a 118-milliliter supply of clobetasol topical shampoo can range from $86.00 to $109.57[2].

Topical Solution

A 25-milliliter supply of clobetasol topical solution can cost between $21.84 and $36.42[2].

Factors Influencing Market Growth

Several factors are driving the growth of the clobetasol propionate market:

  • Increasing R&D Spending: Higher research and development investments are leading to new product developments and improved formulations[3].
  • Growing Demand for Skin Treatments: The rising prevalence of skin conditions such as atopic dermatitis and psoriasis is increasing the demand for effective treatments[4].
  • Economic and Social Factors: Changes in lifestyle, increasing awareness of skin health, and economic growth in emerging markets are also contributing to market growth[4].

Challenges and Limitations

Despite the growth prospects, the market faces several challenges:

  • Regulatory Hurdles: Strict regulatory requirements can slow down the approval process for new formulations.
  • Economic Slowdown: Economic downturns can impact R&D spending and consumer purchasing power.
  • Stock Shortages: Periodic stock shortages can affect the availability and pricing of clobetasol propionate products[2].

Technological Trends and New Product Developments

The market is witnessing significant technological advancements and new product launches. Companies are focusing on developing more effective and user-friendly formulations, such as foams and sprays, which are gaining popularity due to their ease of application and better patient compliance[1].

Key Takeaways

  • The global clobetasol propionate market is expected to grow significantly, driven by increasing demand for skin treatments and R&D spending.
  • The market is segmented by type (purity) and application (formulation type), with high-purity APIs and creams being dominant segments.
  • Regional growth is led by the Asia-Pacific region.
  • Key players are focusing on new product developments and strategic partnerships.
  • Prices vary widely depending on the formulation and quantity.

FAQs

1. What is clobetasol propionate used for? Clobetasol propionate is a potent topical corticosteroid used to treat various skin conditions, including atopic dermatitis, psoriasis, and other dermatological disorders.

2. What is the projected market size of clobetasol propionate by 2030? The global clobetasol propionate market is projected to reach USD 1.6 billion by 2030, growing at a CAGR of 5.7% during the forecast period[4].

3. Which region is expected to drive the growth of the clobetasol propionate market? The Asia-Pacific region is expected to be a significant growth driver due to increasing R&D spending and a large patient population[3].

4. What are the main formulations of clobetasol propionate? Clobetasol propionate is available in various formulations, including aerosol, cream, liniment, scalp dressing, shampoo, and solution[2].

5. How do prices vary for different formulations of clobetasol propionate? Prices vary widely depending on the type of formulation, quantity, and region. For example, a 15-gram supply of clobetasol topical ointment can range from $16.84 to $44.13, while a 118-milliliter supply of shampoo can range from $86.00 to $109.57[2].

Sources

  1. Global Clobetasol Propionate API Market Research Report 2024 - QY Research
  2. Clobetasol topical Prices, Coupons, Copay Cards & Patient Assistance - Drugs.com
  3. Clobetasol Propionate Market to See Huge Demand by 2030 - OpenPR
  4. Clobetasol Propionate Market Size, Share, Scope, Trends And Forecast - Verified Market Reports
  5. Clobex Prices, Coupons, Copay Cards & Patient Assistance - Drugs.com

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.